Frank Kramer

1.1k total citations
27 papers, 583 citations indexed

About

Frank Kramer is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Frank Kramer has authored 27 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Physiology. Recurrent topics in Frank Kramer's work include Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (8 papers) and Cardiac Fibrosis and Remodeling (6 papers). Frank Kramer is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (8 papers) and Cardiac Fibrosis and Remodeling (6 papers). Frank Kramer collaborates with scholars based in Germany, United States and France. Frank Kramer's co-authors include Thomas Krahn, Wilfried Dinh, Hendrik Milting, Michael Coll Barroso, Werner Nickl, Mark Lankisch, Reiner Füth, Thomas Scheffold, Martina I. Klein and Birte Bohms and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of Applied Physiology.

In The Last Decade

Frank Kramer

26 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Kramer Germany 15 352 125 100 99 68 27 583
Kostas Savvatis United Kingdom 7 640 1.8× 90 0.7× 190 1.9× 140 1.4× 44 0.6× 14 832
Giulia Famoso Italy 12 192 0.5× 112 0.9× 54 0.5× 122 1.2× 78 1.1× 29 502
Anita Persson Sweden 7 469 1.3× 106 0.8× 230 2.3× 148 1.5× 67 1.0× 9 852
Virginia Álvarez Spain 17 241 0.7× 153 1.2× 130 1.3× 129 1.3× 74 1.1× 41 505
Roberta Maestri Italy 17 776 2.2× 68 0.5× 190 1.9× 228 2.3× 75 1.1× 23 1.1k
Willem P.T. Ruifrok Netherlands 10 249 0.7× 351 2.8× 209 2.1× 149 1.5× 63 0.9× 14 753
Shigemasa Hashimoto Japan 12 244 0.7× 59 0.5× 99 1.0× 261 2.6× 47 0.7× 20 576
Alexander Jabs Germany 19 446 1.3× 80 0.6× 83 0.8× 335 3.4× 157 2.3× 36 766
Dhakshinamurthy Vijay Anand United Kingdom 5 463 1.3× 85 0.7× 165 1.6× 252 2.5× 64 0.9× 10 796
Miry Blich Israel 13 261 0.7× 35 0.3× 159 1.6× 119 1.2× 92 1.4× 29 698

Countries citing papers authored by Frank Kramer

Since Specialization
Citations

This map shows the geographic impact of Frank Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kramer more than expected).

Fields of papers citing papers by Frank Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kramer. The network helps show where Frank Kramer may publish in the future.

Co-authorship network of co-authors of Frank Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kramer. A scholar is included among the top collaborators of Frank Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kramer. Frank Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buhl, Derek L., Joseph M. Dzierzewski, Frank Kramer, et al.. (2025). A patient first perspective of sleep disturbance across therapeutic areas: a systematic literature review of qualitative studies. Quality of Life Research. 34(7). 1849–1867.
2.
Kalamegham, Rasika, et al.. (2023). Incorporating digitally derived endpoints within clinical development programs by leveraging prior work. npj Digital Medicine. 6(1). 139–139. 9 indexed citations
3.
Butler, Javed, Muhammad Shahzeb Khan, Tomasz Gąsior, et al.. (2023). Accelerometer vs. Other Activity Measures in Heart Failure with Preserved Ejection Fraction: The VITALITY-HFpEF Trial. ESC Heart Failure. 11(1). 293–298. 5 indexed citations
4.
Kramer, Frank, Sebastian Voß, Lothar Roessig, et al.. (2020). Evaluation of High-Sensitivity C-Reactive Protein and Uric Acid in Vericiguat-Treated Patients with Heart Failure with Reduced Ejection Fraction. European Journal of Heart Failure. 22(9). 1675–1683. 30 indexed citations
5.
Hoppe, Matthias, Philip Boehme, Thomas Krahn, et al.. (2019). Test-Retest Reliability of Non-Invasive Cardiac Output Measurement during Exercise in Healthy Volunteers in Daily Clinical Routine. Arquivos Brasileiros de Cardiologia. 113(2). 231–239. 4 indexed citations
6.
Vaduganathan, Muthiah, Stefan D. Anker, Stefano Coiro, et al.. (2018). Mobile health applications in cardiovascular research. International Journal of Cardiology. 269. 265–271. 15 indexed citations
7.
Kramer, Frank, Hani N. Sabbah, Faı̈ez Zannad, et al.. (2017). Redefining the role of biomarkers in heart failure trials: expert consensus document. Heart Failure Reviews. 22(3). 263–277. 16 indexed citations
8.
Barroso, Michael Coll, Philip Boehme, Frank Kramer, et al.. (2017). Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction. Arquivos Brasileiros de Cardiologia. 109(5). 448–456. 15 indexed citations
9.
Barroso, Michael Coll, Frank Kramer, Stephen J. Greene, et al.. (2016). Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction. BMC Cardiovascular Disorders. 16(1). 199–199. 40 indexed citations
10.
Kramer, Frank & Wilfried Dinh. (2016). Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications. Archiv der Pharmazie. 349(6). 399–409. 7 indexed citations
11.
Böthig, Dietmar, Frank Kramer, Birte Bohms, et al.. (2013). The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices. The Journal of Heart and Lung Transplantation. 32(2). 221–230. 22 indexed citations
12.
Kramer, Frank. (2013). Galectin-3: clinical utility and prognostic value in patients with heart failure. SHILAP Revista de lepidopterología. 13–13. 14 indexed citations
13.
Nickl, Werner, Reiner Füth, Till Köhler, et al.. (2012). Avaliação da área valvar aórtica combinando ecocardiografia e ressonância magnética. Arquivos Brasileiros de Cardiologia. 98(3). 234–242. 6 indexed citations
14.
Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2011). Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 28 indexed citations
15.
Kramer, Frank & Hendrik Milting. (2011). Novel biomarkers in human terminal heart failure and under mechanical circulatory support. Biomarkers. 16(sup1). S31–S41. 16 indexed citations
16.
Dinh, Wilfried, Mark Lankisch, Werner Nickl, et al.. (2010). Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovascular Diabetology. 9(1). 63–63. 70 indexed citations
17.
18.
Schumann, Christian, Philipp M. Lepper, Roland Schneiderbauer, et al.. (2010). Circulating biomarkers of tissue remodelling in pulmonary hypertension. Biomarkers. 15(6). 523–532. 48 indexed citations
19.
Milting, Hendrik, Peter Ellinghaus, Michael J. Seewald, et al.. (2008). Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices. The Journal of Heart and Lung Transplantation. 27(6). 589–596. 125 indexed citations
20.
Kramer, Frank, Peter Sandner, Martina I. Klein, & Thomas Krahn. (2008). Plasma concentrations of matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1 and osteopontin reflect severity of heart failure in DOCA-salt hypertensive rat. Biomarkers. 13(3). 270–281. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kostas Savvatis Breakdown of academic impact, for papers by Giulia Famoso Breakdown of academic impact, for papers by Anita Persson Breakdown of academic impact, for papers by Virginia Álvarez Breakdown of academic impact, for papers by Roberta Maestri Breakdown of academic impact, for papers by Willem P.T. Ruifrok Breakdown of academic impact, for papers by Shigemasa Hashimoto Breakdown of academic impact, for papers by Alexander Jabs Breakdown of academic impact, for papers by Dhakshinamurthy Vijay Anand Breakdown of academic impact, for papers by Miry Blich
Rankless by CCL
2026